132 related articles for article (PubMed ID: 2866300)
1. Pseudomonas aeruginosa: clinical manifestations and management.
Gould IM; Wise R
Lancet; 1985 Nov; 2(8466):1224-7. PubMed ID: 2866300
[No Abstract] [Full Text] [Related]
2. Control of infection following burn injury.
Alexander JW
Arch Surg; 1971 Oct; 103(4):435-41. PubMed ID: 5094548
[No Abstract] [Full Text] [Related]
3. [Pseudomonas aeruginosa. A pathogenic microbe of current importance].
Bergan T
Tidsskr Nor Laegeforen; 1969 Jun; 89(12):1014-6. PubMed ID: 4979183
[No Abstract] [Full Text] [Related]
4. [Pyocyaneus infection in surgery].
Kolker II; Stanislavskiĭ ES
Sov Med; 1979 Sep; (9):86-92. PubMed ID: 388670
[No Abstract] [Full Text] [Related]
5. [On infection with Pseudomonas aeruginosa (B. pyocyaneum)].
Wöckel W
Dtsch Med Wochenschr; 1967 Oct; 92(41):1876-80. PubMed ID: 4964395
[No Abstract] [Full Text] [Related]
6. [Pseudomonas aeruginosa in dermatology].
el Baze P; Lacour JP; Ortonne JP
Ann Dermatol Venereol; 1985; 112(11):925-34. PubMed ID: 3937475
[No Abstract] [Full Text] [Related]
7. Pseudomonas aeruginosa burn wound infection in a dedicated paediatric burns unit.
Naqvi SH; Naqvi SH
S Afr J Surg; 2013 Oct; 51(4):151-2. PubMed ID: 24209702
[No Abstract] [Full Text] [Related]
8. [Role of Pseudomonas aeruginosa in infection in burn patients].
Guilbaud J; Dhennin C; Carsin H
Presse Med; 1984 Mar; 13(13):825-9. PubMed ID: 6231605
[TBL] [Abstract][Full Text] [Related]
9. [Immunotherapy with monovalent Pseudomonas aeruginosa vaccine in chronic bronchopulmonary infections].
Popescu C; Meitert E; Russ R; Meitert T; Sima F; Savulian C; Esrig E
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983; 32(3):261-72. PubMed ID: 6318298
[No Abstract] [Full Text] [Related]
10. Ecthyma gangrenosum in a burned child.
Eldridge JP; Baldridge ED; MacMillan BG
Burns Incl Therm Inj; 1986 Dec; 12(8):578-85. PubMed ID: 3454691
[TBL] [Abstract][Full Text] [Related]
11. Serratia sp. infections in cancer patients.
Bodey GP; Rodriguez V; Smith JP
Cancer; 1970 Jan; 25(1):199-205. PubMed ID: 5410310
[No Abstract] [Full Text] [Related]
12. Dr Coetzee responds.
Coetzee E
S Afr J Surg; 2013 Nov; 51(4):152. PubMed ID: 24479209
[No Abstract] [Full Text] [Related]
13. Erysipelaslike lesions and hyperesthesia as manifestations of Pseudomonas aeruginosa sepsis.
Roberts R; Tarpay MM; Marks MI; Nitschke R
JAMA; 1982 Nov; 248(17):2156-7. PubMed ID: 6811771
[No Abstract] [Full Text] [Related]
14. Therapeutical pseudomonas aeruginosa antisera. Preparation, control and administration.
Meitert T; Meitert E; Szegli G; Peligrad I
Arch Roum Pathol Exp Microbiol; 1982; 41(2):115-21. PubMed ID: 6816189
[No Abstract] [Full Text] [Related]
15. Outbreak of hospital infection caused by contaminated autoclaved fluids.
Phillips I; Eykyn S; Laker M
Lancet; 1972 Jun; 1(7763):1258-60. PubMed ID: 4113517
[No Abstract] [Full Text] [Related]
16. Pseudomonas diseases.
White A; Crowder JG
Adv Intern Med; 1975; 20():23-35. PubMed ID: 46688
[No Abstract] [Full Text] [Related]
17. Pseudomonas skin infection: clinical features, epidemiology, and management.
Wu DC; Chan WW; Metelitsa AI; Fiorillo L; Lin AN
Am J Clin Dermatol; 2011 Jun; 12(3):157-69. PubMed ID: 21469761
[TBL] [Abstract][Full Text] [Related]
18. Group C streptococci, epidemiologic markers and implications in human pathology.
Mihalcu F; Vereanu A; Andronescu C; Dumitriu S
Arch Roum Pathol Exp Microbiol; 1982; 41(2):123-31. PubMed ID: 7149957
[No Abstract] [Full Text] [Related]
19. Pseudomonas aeruginosa burn wound infection in a dedicated paediatric burns unit.
Coetzee E; Rode H; Kahn D
S Afr J Surg; 2013 May; 51(2):50-3. PubMed ID: 23725892
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of antibodies against the N-terminal of Pseudomonas aeruginosa flagellin for treating infections in a murine burn wound model.
Barnea Y; Carmeli Y; Gur E; Kuzmenko B; Gat A; Neville LF; Eren R; Dagan S; Navon-Venezia S
Plast Reconstr Surg; 2006 Jun; 117(7):2284-91. PubMed ID: 16772930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
